DH logo

Definitive Healthcare Corp. (DH)

$2.31

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on DH

Market cap

$238630824

EPS

-1.69

P/E ratio

--

Price to sales

0.98

Dividend yield

--

Beta

1.606354

Price on DH

Previous close

$2.30

Today's open

$2.27

Day's range

$2.24 - $2.32

52 week range

$2.15 - $5.68

Profile about DH

CEO

Kevin Coop

Employees

782

Headquarters

Framingham, MA

Exchange

Nasdaq Global Select

Shares outstanding

103303387

Issue type

Common Stock

DH industries and sectors

Healthcare

Healthcare Providers & Services

News on DH

Definitive Healthcare Corp. (DH) Q3 2025 Earnings Call Transcript

Definitive Healthcare Corp. ( DH ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Jonathan Paris - Chief Legal Officer & Secretary Kevin Coop - CEO & Director Casey Heller - Chief Financial Officer Conference Call Participants Jared Haase - William Blair & Company L.L.C., Research Division Nishad Patwardhan - Goldman Sachs Group, Inc., Research Division Johnathan McCary - Raymond James & Associates, Inc., Research Division Jenny Shen - BTIG, LLC, Research Division David Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Welcome to Definitive Healthcare's Q3 2025 Earnings Call.

news source

Seeking Alpha • Nov 7, 2025

news preview

Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2025

FRAMINGHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended September 30, 2025.

news source

GlobeNewsWire • Nov 6, 2025

news preview

Definitive Healthcare Corp. (DH) Beats Q3 Earnings and Revenue Estimates

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.1 per share a year ago.

news source

Zacks Investment Research • Nov 7, 2025

news preview

Definitive Healthcare Announces Timing of Its Third Quarter 2025 Financial Results Conference Call and Webcast

FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2025, on Thursday, November 6, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.

news source

GlobeNewsWire • Oct 23, 2025

news preview

Forum Ventures Bets Big on Category-Defining Vertical AI Solution for Healthcare Growth, Salubrum

New York City, NY, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Salubrum, a vertical artificial intelligence (AI) company, has launched a category-defining commercialization engine for healthcare growth. In an industry where legacy agencies struggle to scale, Salubrum's AI-first approach productizes and automates the traditional marketing agency. Salubrum has partnered with industry giant Definitive Healthcare (NASDAQ: DH) to provide best-in-class precision patient activation, reimagining how healthcare brands go to market.

news source

GlobeNewsWire • Oct 17, 2025

news preview

What Makes Definitive Healthcare (DH) a New Buy Stock

Definitive Healthcare (DH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

news source

Zacks Investment Research • Oct 13, 2025

news preview

Definitive Healthcare Corp. (DH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Definitive Healthcare Corp. (NASDAQ:DH ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 9:15 AM EDT Company Participants Kevin Coop - CEO & Director Casey Heller - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley, Research Division Presentation Craig Hettenbach VP & Equity Analyst All right. Great. Well, good morning, everyone.

news source

Seeking Alpha • Sep 9, 2025

news preview

Definitive Healthcare to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

FRAMINGHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Executive Officer, Kevin Coop, and Chief Financial Officer, Casey Heller, will present at the Morgan Stanley 23rd Annual Global Healthcare Conference.

news source

GlobeNewsWire • Sep 2, 2025

news preview

DH vs. BL: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Internet - Software sector have probably already heard of Definitive Healthcare Corp. (DH) and BlackLine (BL). But which of these two stocks offers value investors a better bang for their buck right now?

news source

Zacks Investment Research • Aug 19, 2025

news preview

Definitive Healthcare Corp. (DH) Q2 2025 Earnings Call Transcript

Definitive Healthcare Corp. (NASDAQ:DH ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Casey Heller - Chief Financial Officer Jonathan Paris - Chief Legal Officer Kevin D. Coop - CEO & Director Conference Call Participants David Michael Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division George Robert Hill - Deutsche Bank AG, Research Division Johnathan M.

news source

Seeking Alpha • Aug 8, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Definitive Healthcare Corp.

Open an M1 investment account to buy and sell Definitive Healthcare Corp. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in DH on M1